CERVINO
A Phase 3, Multicenter, Randomized, Open Label Study of ABBV-383 Compared With Standard Available Therapies in Subjects With Relapsed or Refractory Multiple Myeloma (3L+ RRMM Monotherapy Study)
Filters
Save & Share
Clear Filters
Location
Explore options near your patient - or anywhere in the US.
Diagnosis
Treatment History
BCMA Therapy
This stands for B Cell Maturation Antigen (BCMA) and includes treatments such as ide-cel, cilta-cel or belantamab mafodotin.
Near Add Your Location
Sorting 11 by
- Accepting patients
American Oncology Partners of Maryland (Bethesda)
The Center for Cancer & Blood Disorders - Bethesda
Bethesda, MD
- Accepting patients
New York Cancer & Blood Specialists (Bay Shore)
Bay Shore, NY
- Accepting patients
New York Cancer and Blood Specialists
New York, NY
- Accepting patients
- Accepting patients
- Accepting patients
Providence St. Jude Medical Center
Fullerton, CA
- Accepting patients
Cancer Specialists of North Florida - Southpoint
Jacksonville, FL
- Accepting patients
- Accepting patients
University of Illinois at Chicago
Chicago, IL
- Accepting patients
1,363 hidden based on your filters. Show All
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.